fda shortage tirzepatide update confirms is still over, gives compounders a grace period FDA Faces Law Suit Over

Mismanaged use can be extremely costly, damaging, and economically counterproductive, leading to lean mass loss, malnutrition, orthostatic events, injury, poor adherence, and rebound weight gain. Thats why organizations, including the Obesity Society and American Association of Clinical Endocrinology, continue to emphasize the importance of long-term care, not just for weight loss, but for weight maintenance and overall cardiometabolic health

Several figures in that table are given without a citation, so treat them as the article's own summary rather than verified trial output

Individual results vary significantly from person to person

Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ

G, MD, FAAP